The UK's BioIndustry Association has welcomed the publication of the Bioscience 2015 Review and Refresh report. The group, which includes the country's biotechnology drugmakers, said the recommendations build on those in the original Bioscience 2015 report published in 2003. The new report was produced by a committee chaired by Sir David Cooksey, which included biotechnology firms, the finance community, patient groups, research councils, academia and input from various government departments.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze